Latest news
LifeMine CEO Verdine Raises $263M From Bezos and Gates to Replace Tacrolimus, the Transplant Drug That Destroys Kidneys - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 13:09:00 GMTBezos, Gates back LifeMine's transplant aspirations in $263M raise - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 10:31:57 GMT